Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Puerperal Infection | 2 | 2018 | 26 | 1.43 | Why? |
| Obstetrics | 5 | 2018 | 859 | 1.01 | Why? |
| Peripartum Period | 3 | 2019 | 89 | 0.90 | Why? |
| Maternal Mortality | 4 | 2018 | 461 | 0.90 | Why? |
| Pregnancy Complications, Infectious | 15 | 2022 | 11559 | 0.86 | Why? |
| Microcephaly | 1 | 2020 | 181 | 0.74 | Why? |
| Lactation | 2 | 2021 | 361 | 0.71 | Why? |
| Pregnancy Complications | 3 | 2017 | 1388 | 0.68 | Why? |
| Obstetric Labor Complications | 1 | 2017 | 119 | 0.64 | Why? |
| Pregnancy | 30 | 2022 | 23879 | 0.60 | Why? |
| Prejudice | 1 | 2018 | 245 | 0.58 | Why? |
| Abortion, Spontaneous | 2 | 2018 | 776 | 0.58 | Why? |
| Medication Therapy Management | 1 | 2017 | 312 | 0.51 | Why? |
| Prenatal Exposure Delayed Effects | 1 | 2017 | 319 | 0.49 | Why? |
| Pregnant Women | 4 | 2021 | 2535 | 0.46 | Why? |
| Maternal Health Services | 2 | 2017 | 808 | 0.46 | Why? |
| Immunization Schedule | 4 | 2018 | 1305 | 0.40 | Why? |
| Bacteremia | 2 | 2019 | 1372 | 0.40 | Why? |
| Ebolavirus | 1 | 2017 | 834 | 0.40 | Why? |
| Zika Virus | 1 | 2020 | 1924 | 0.34 | Why? |
| Zika Virus Infection | 1 | 2020 | 1920 | 0.32 | Why? |
| Fever | 3 | 2019 | 7795 | 0.32 | Why? |
| Influenza Vaccines | 4 | 2018 | 2941 | 0.30 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2017 | 1475 | 0.30 | Why? |
| Healthcare Disparities | 2 | 2017 | 3893 | 0.25 | Why? |
| Streptococcus agalactiae | 1 | 2003 | 194 | 0.23 | Why? |
| Practice Patterns, Physicians' | 4 | 2018 | 4927 | 0.21 | Why? |
| Postpartum Period | 2 | 2018 | 936 | 0.21 | Why? |
| Gynecology | 2 | 2018 | 741 | 0.21 | Why? |
| Antibiotic Prophylaxis | 1 | 2003 | 399 | 0.20 | Why? |
| Uganda | 3 | 2018 | 1057 | 0.20 | Why? |
| Streptococcal Infections | 1 | 2003 | 255 | 0.20 | Why? |
| Uterine Diseases | 1 | 2019 | 13 | 0.20 | Why? |
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2019 | 33 | 0.19 | Why? |
| Cesarean Section | 2 | 2020 | 2089 | 0.19 | Why? |
| Pregnancy Complications, Neoplastic | 1 | 2018 | 79 | 0.18 | Why? |
| Hypothermia | 1 | 2018 | 59 | 0.18 | Why? |
| Immunization | 2 | 2018 | 2019 | 0.18 | Why? |
| Quality Improvement | 4 | 2018 | 2435 | 0.17 | Why? |
| Aggression | 1 | 2018 | 126 | 0.17 | Why? |
| Infant, Newborn | 6 | 2021 | 23105 | 0.17 | Why? |
| Acinetobacter | 1 | 2017 | 58 | 0.17 | Why? |
| Female | 32 | 2022 | 380317 | 0.17 | Why? |
| Family Planning Services | 2 | 2017 | 236 | 0.17 | Why? |
| Neonatal Sepsis | 1 | 2017 | 69 | 0.16 | Why? |
| Influenza, Human | 3 | 2018 | 10779 | 0.16 | Why? |
| Puerperal Disorders | 1 | 2019 | 151 | 0.16 | Why? |
| Placenta Diseases | 1 | 2018 | 180 | 0.16 | Why? |
| Cohort Studies | 5 | 2020 | 36005 | 0.15 | Why? |
| Africa, Western | 1 | 2017 | 363 | 0.15 | Why? |
| Fetal Diseases | 1 | 2017 | 182 | 0.15 | Why? |
| Cephalosporins | 1 | 2017 | 250 | 0.14 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2017 | 635 | 0.14 | Why? |
| Health Services Research | 2 | 2017 | 756 | 0.14 | Why? |
| Pain, Postoperative | 1 | 2018 | 289 | 0.14 | Why? |
| Clinical Competence | 3 | 2018 | 3263 | 0.14 | Why? |
| Colonic Neoplasms | 1 | 2018 | 295 | 0.14 | Why? |
| Vaccines | 3 | 2018 | 3692 | 0.13 | Why? |
| Acinetobacter Infections | 1 | 2017 | 273 | 0.13 | Why? |
| Epidemiologic Methods | 1 | 2017 | 392 | 0.13 | Why? |
| Research Support as Topic | 1 | 2017 | 327 | 0.13 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.13 | Why? |
| Practice Guidelines as Topic | 5 | 2020 | 15421 | 0.12 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2017 | 694 | 0.12 | Why? |
| Vaccination | 7 | 2021 | 19050 | 0.12 | Why? |
| Prenatal Care | 2 | 2019 | 1314 | 0.12 | Why? |
| Case-Control Studies | 3 | 2022 | 17671 | 0.12 | Why? |
| Adenocarcinoma | 1 | 2018 | 651 | 0.11 | Why? |
| Humans | 34 | 2022 | 930598 | 0.11 | Why? |
| Placenta | 1 | 2022 | 1531 | 0.11 | Why? |
| Delivery, Obstetric | 1 | 2020 | 1292 | 0.11 | Why? |
| United States | 10 | 2020 | 46150 | 0.10 | Why? |
| Perinatal Care | 1 | 2017 | 576 | 0.10 | Why? |
| Prospective Studies | 6 | 2022 | 43301 | 0.10 | Why? |
| RNA, Messenger | 2 | 2021 | 5131 | 0.10 | Why? |
| Guideline Adherence | 1 | 2003 | 2309 | 0.10 | Why? |
| Advisory Committees | 4 | 2018 | 1418 | 0.10 | Why? |
| Drug Resistance, Bacterial | 1 | 2019 | 1414 | 0.09 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 1115 | 0.09 | Why? |
| Analgesics, Opioid | 1 | 2018 | 1070 | 0.09 | Why? |
| Data Collection | 1 | 2017 | 1769 | 0.09 | Why? |
| Pregnancy Outcome | 2 | 2020 | 3803 | 0.08 | Why? |
| Minority Groups | 1 | 2017 | 1631 | 0.08 | Why? |
| New York City | 1 | 2020 | 7432 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2018 | 1666 | 0.08 | Why? |
| Infectious Disease Transmission, Vertical | 2 | 2020 | 5164 | 0.07 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.07 | Why? |
| Adult | 16 | 2022 | 244371 | 0.07 | Why? |
| Hemorrhage | 1 | 2017 | 3013 | 0.07 | Why? |
| Rural Population | 1 | 2018 | 2408 | 0.07 | Why? |
| Pneumonia, Viral | 4 | 2021 | 243684 | 0.07 | Why? |
| Referral and Consultation | 2 | 2018 | 4816 | 0.07 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.07 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.06 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.06 | Why? |
| Incidence | 3 | 2019 | 25622 | 0.06 | Why? |
| Pregnancy Trimester, Third | 1 | 2003 | 445 | 0.06 | Why? |
| Clinical Trials as Topic | 1 | 2021 | 7330 | 0.05 | Why? |
| National Institute of Child Health and Human Development (U.S.) | 1 | 2019 | 24 | 0.05 | Why? |
| Pregnancy, High-Risk | 1 | 2020 | 128 | 0.05 | Why? |
| Physicians | 1 | 2018 | 4214 | 0.05 | Why? |
| Fetal Blood | 1 | 2021 | 573 | 0.04 | Why? |
| Tetanus | 1 | 2017 | 61 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Infant | 2 | 2018 | 30274 | 0.04 | Why? |
| Diphtheria | 1 | 2017 | 74 | 0.04 | Why? |
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2017 | 91 | 0.04 | Why? |
| Decision Trees | 1 | 2019 | 441 | 0.04 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.04 | Why? |
| Age of Onset | 1 | 2018 | 557 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Gestational Age | 1 | 2022 | 1488 | 0.04 | Why? |
| Treatment Refusal | 1 | 2018 | 211 | 0.04 | Why? |
| Inflammation | 1 | 2019 | 13255 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.04 | Why? |
| Whooping Cough | 1 | 2017 | 201 | 0.04 | Why? |
| Hepatitis B Vaccines | 1 | 2017 | 245 | 0.04 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.03 | Why? |
| Patient Acuity | 1 | 2022 | 1755 | 0.03 | Why? |
| Meningococcal Vaccines | 1 | 2017 | 225 | 0.03 | Why? |
| Massachusetts | 1 | 2018 | 1279 | 0.03 | Why? |
| Ischemia | 1 | 2022 | 901 | 0.03 | Why? |
| CD4 Lymphocyte Count | 1 | 2018 | 1517 | 0.03 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Papillomavirus Vaccines | 1 | 2017 | 405 | 0.03 | Why? |
| Hepatitis B | 1 | 2018 | 888 | 0.03 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.03 | Why? |
| Health Personnel | 2 | 2017 | 29646 | 0.03 | Why? |
| Patient Positioning | 1 | 2020 | 1505 | 0.02 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.02 | Why? |
| Fatal Outcome | 1 | 2018 | 3438 | 0.02 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.02 | Why? |
| Disease Outbreaks | 1 | 2017 | 27595 | 0.02 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.02 | Why? |
| Male | 5 | 2020 | 367725 | 0.02 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| Thromboembolism | 1 | 2020 | 2101 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.02 | Why? |
| Immunization Programs | 1 | 2017 | 2006 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2017 | 3228 | 0.02 | Why? |
| Liver | 1 | 2018 | 4007 | 0.02 | Why? |
| Decision Making | 1 | 2018 | 3132 | 0.02 | Why? |
| Surveys and Questionnaires | 2 | 2021 | 43792 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2019 | 11304 | 0.01 | Why? |
| Time Factors | 1 | 2003 | 31397 | 0.01 | Why? |
| Patient Acceptance of Health Care | 1 | 2018 | 5002 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2019 | 22971 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Middle Aged | 3 | 2018 | 270681 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.00 | Why? |
| Aged | 1 | 2018 | 215776 | 0.00 | Why? |
Riley's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(158)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(66)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_